MIRA Pharmaceuticals, Inc.MIRANASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank60
3Y CAGR-3.9%
5Y CAGR+169.6%
Year-over-Year Change
Research and development spending
3Y CAGR
-3.9%/yr
Annual compound
5Y CAGR
+169.6%/yr
Recent deceleration
Percentile
P60
Within normal range
vs 5Y Ago
142.3x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.08M | -36.9% |
| 2024 | $3.31M | +110.1% |
| 2023 | $1.57M | -33.1% |
| 2022 | $2.35M | +243.6% |
| 2021 | $684447.00 | +4573.0% |
| 2020 | $14647.00 | - |